Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECISION: Dextenza for Pre-surgical Ocular Surface Treatment
NCT04530864Phase 4Unknown
- Sponsor
- PRISM Vision Group
- Start
- Jan 2021
- Primary completion
- Jan 2021
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
01
Overview
A Phase 4 trial of ozurdex in dry eye disease (DED), ocular surface disease (OSD), sponsored by PRISM Vision Group. Status: unknown.
02
Drugs
ozurdex
03
Conditions
dry eye disease (DED)ocular surface disease (OSD)
Beyond the preview
Go deeper on NCT04530864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04530864.